「膵神経内分泌腫瘍におけるクロマチンリモデリング因子異常と腫瘍進展・予後との関連」の関連論文
-
口腔白板症におけるp62発現と臨床病理的因子の解析
-
The transcription factor Klf5 is essential for intrahepatic biliary epithelial tissue remodeling against liver injury
-
乳がん患者由来オルガノイドの腫瘍内不均一性の検討と,その背後にある分子生物学的特徴の探索
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
-
大腸癌の抗EGFR抗体薬感受性に関与するDNAメチル化異常と遺伝子発現の関連性
-
Understanding the functional role of selected bioactive compounds and altered genes on gastric carcinogenesis of the differentiated subtype using A4gnt-deficient mice model
-
Pathological studies on canine cutaneous epithelial tumors
-
混合型神経内分泌腫瘍における腫瘍組織微小環境の病理学的検討
-
A Clinicopathological Study of Metachronous Anaplastic Carcinoma Transformed from Recurrent Papillary Thyroid Carcinoma
-
Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma
-
Identification and Functional Analysis of Genes Critical to Tumorigenesis
-
小児固形腫瘍に対する多層性解析による新規標的治療の創出
-
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
-
時計遺伝子CLOCKの発現に着目した乳がん幹細胞の新規治療法に関する研究
-
Prognostic role of the innate immune signature CD163 and
-
Prognostic role of the innate immune signature CD163 and
-
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
-
腫瘍の進行におけるProtease-Activated Receptor-2の役割に関する研究
-
初発・再発膠芽腫組織を使用した腫瘍微小環境の変化の解析とテモゾロミド耐性TS細胞に対する抗PD-L1抗体+M2マクロファージ阻害剤併用療法の検討
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
-
Molecular pathogenesis of bone marrow disorders in dogs
-
乳腺腫瘍増殖におけるテネイシンCの役割
-
Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator
-
ヒドロキシメチルシトシンの網羅的解析によるグリオーマ悪性転化機構の解明
-
Phosphorylated proteome analysis of a novel germline ABL1 mutation causing an autosomal dominant syndrome with ventricular septal defect
-
Studies on TP53 gene mutations in canine histiocytic sarcoma
-
Epstein-Barr Virus関連腫瘍におけるウイルス遺伝子発現と免疫回避・発癌機構の解明
-
去勢抵抗性前立腺がんで発現上昇する遺伝子の機能ならびにその臨床的意義の解析
-
RNAスプライシングに関連する遺伝子の変異を有する骨髄異形成症候群に関する検討
-
Ependymoma-like tumors with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: a hitherto unclassified tumor related to ependymoma
-
肝生検検体を用いた原発性硬化性胆管炎の病態解明
-
Role of PD-L1 expression during the progression of submucosal gastric cancer
-
膵癌における腹腔洗浄液を用いたリキッドバイオプシーの臨床的有用性の検討
-
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia
-
Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease
-
術前化学放射線療法を施行した食道扁平上皮癌におけるKeap1 - Nrf2経路関連因子,TXNRD1及びHO-1の病理学的検討
-
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
-
Wnt経路を標的とした悪性骨腫瘍の病態解析とスクレロスチンによる治療の臨床応用
-
Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer
-
消化管癌における分泌型プロテアーゼの発現異常と悪性形質との関連
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
膵・消化管神経内分泌腫瘍(NEN)肝転移に対する超音波造影剤の有用性およびNEN におけるmTORシグナル伝達経路関連タンパク発現の腫瘍学的意義
-
Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the EPHA2-PARD3 axis as a cancer vulnerability in KRAS-mutant colorectal cancer
-
骨肉腫と免疫細胞の相互作用の解明による骨肉腫に対する新規治療標的の探索
-
大腸鋸歯状腺腫の内視鏡及び網羅的遺伝子発現解析による検討
-
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma